After paring costs and redirecting its research activities, Sanofi-Aventis ended 2009 with a net income of €8.5 billion, up by 12.8% at constant exchange rates on net sales of €29.3 billion, up by 5.3%. It sees further earnings growth in 2010. ---Subscribe to MedNous to access this article--- Company News
